Trial Profile
A phase II trial of vinflunine as salvage chemotherapy in hormone refractory prostate cancer (HRPC).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2021
Price :
$35
*
At a glance
- Drugs Vinflunine (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 27 Oct 2007 New trial record.